PPAR activation induces m1 macrophage polarization via cPLACOX-2 inhibition, activating ros production against Leishmania Mexicana

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Diaz Gandarilla J A ^a   Osorio Trujillo, C ^a   Hernandez Ramirez V I ^a   Talamas Rohana P ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CYCLOOXYGENASE 2 INHIBITOR; ISOMERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2 GROUP IV; PLA2G4C PROTEIN, HUMAN; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PTGS2 PROTEIN, HUMAN;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; LEISHMANIA MEXICANA; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITE LOAD; POLARIZATION; PROTEIN EXPRESSION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM; PARASITOLOGY; PATHOGENICITY; SKIN LEISHMANIASIS;

LEISHMANIA MEXICANA;

ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; GROUP IV PHOSPHOLIPASES A2; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LEISHMANIA MEXICANA; LEISHMANIASIS, DIFFUSE CUTANEOUS; MACROPHAGES; MICE; PPAR GAMMA; REACTIVE OXYGEN SPECIES;

EID: 84875473890     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/215283     Document Type: Article

References (49)

1. Who, Leishmaniasis. 2012, http://www.who.int/topics/leishmaniasis/en/
2. Torrentera F. A., Lambot M. A., Laman J. D., Van Meurs M., Kiss R., Noël J. C., Carlier Y., Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana. American Journal of Tropical Medicine and Hygiene 2002 66 3 273 279 2-s2.0-0036311346 (Pubitemid 34756096)
3. Rosas L. E., Keiser T., Barbi J., Satoskar A. A., Septer A., Kaczmarek J., Lezama-Davila C. M., Satoskar A. R., Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. International Immunology 2005 17 10 1347 1357 2-s2.0-27144473298 10.1093/intimm/dxh313 (Pubitemid 41488008)
4. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-β and-γ in the adult rat. Endocrinology 1996 137 1 354 366 2-s2.0-0030047806 10.1210/en.137.1.354 (Pubitemid 26005011)
5. Chan M. M., Evans K. W., Moore A. R., Fong D., Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections. Journal of Biomedicine & Biotechnology 2010 2010 9 10.1155/2010/828951 828951
6. Ritter U., Mattner J., Rocha J. S., Bogdan C., Körner H., The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Microbes and Infection 2004 6 6 559 565 2-s2.0-2542502699 10.1016/j.micinf.2004.02.008 (Pubitemid 38680597)
7. Chatelain R., Mauze S., Coffman R. L., Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunology 1999 21 4 211 218 2-s2.0-0032898950 10.1046/j.1365-3024.1999.00224.x (Pubitemid 29158767)
8. Padigel U. M., Alexander J., Farrell J. P., The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. Journal of Immunology 2003 171 7 3705 3710 2-s2.0-0141886173 (Pubitemid 37254575)
9. Krakauer T., Molecular therapeutic targets in inflammation: cyclooxygenase and NF- B. Current Drug Targets 2004 3 3 317 324 2-s2.0-4444263810 10.2174/1568010043343714 (Pubitemid 39206661)
10. 2) is partially dependent on the induction of dual specificity phosphatase 1 (DUSP-1) in vitro and in vivo. Osteoarthritis and Cartilage 2008 16 supplement 4 S190 S191
11. 2-dependent transcriptional suppression of cytokine-induced tumor necrosis factor- gene expression in human macrophages and rheumatoid arthritis-affected synovial fibroblasts. Journal of Biological Chemistry 2005 280 10 9536 9546 2-s2.0-15744387863 10.1074/jbc.M414067200 (Pubitemid 40409649)
12. 2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. Journal of Pharmacology and Experimental Therapeutics 2002 303 3 1001 1006 2-s2.0-0036882078 10.1124/jpet.102.041244 (Pubitemid 35424382)
13. He W., Pelletier J. P., Martel-Pelletier J., Laufer S., Di Battista J. A., Synthesis of interleukin 1 β tumor necrosis factor- and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines. Journal of Rheumatology 2002 29 3 546 553 2-s2.0-0036009043 (Pubitemid 34202826)
14. Pérez-Santos J. L. M., Talamás-Rohana P., In vitro indomethacin administration upregulates interleukin-12 production and polarizes the immune response towards a Th1 type in susceptible BALB/c mice infected with Leishmania mexicana. Parasite Immunology 2001 23 11 599 606 2-s2.0-0035725122 10.1046/j.1365-3024.2001.00421.x (Pubitemid 34205870)
15. Van Assche T., Deschacht M., Da Luz R. A. I., Maes L., Cos P., Leishmania -macrophage interactions: insights into the redox biology. Free Radical Biology and Medicine 2011 51 2 337 351 10.1016/j.freeradbiomed.2011.05.011
16. Estrada-Figueroa L. A., Ramírez-Jiménez Y., Osorio-Trujillo C., Shibayama M., Navarro-García F., García-Tovar C., Talamás-Rohana P., Absence of CD38 delays arrival of neutrophils to the liver and innate immune response development during hepatic amoebiasis by Entamoeba histolytica. Parasite Immunology 2011 33 12 661 668 10.1111/j.1365-3024.2011.01333.x
17. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
18. Nessa K., Palmberg L., Johard U., Malmberg P., Jarstrand C., Camner P., Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. Environmental Research 1997 75 2 141 148 2-s2.0-0031278617 10.1006/enrs.1997.3788 (Pubitemid 28022908)
19. Muñoz R., Alfaro W., Estandarización de la técnica de reducción del NBT mediante lectura en placas de microELISA. Revista Médica del Hospital Nacional de Niños Dr. Carlos Sáenz Herrera 2000 35 29 39
20. Straus D. S., Glass C. K., Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends in Immunology 2007 28 12 551 558 2-s2.0-36049034344 10.1016/j.it.2007.09.003 (Pubitemid 350101420)
21. Bright J. J., Kanakasabai S., Chearwae W., Chakraborty S., PPAR regulation of inflammatory signaling in CNS diseases. PPAR Research 2008 2008 12 2-s2.0-49749088893 10.1155/2008/658520 658520
22. Ringseis R., Schulz N., Saal D., Eder K., Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix- metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. Journal of Nutritional Biochemistry 2008 19 9 594 603 2-s2.0-48649087711 10.1016/j.jnutbio.2007.08.003
23. Matte C., Olivier M., Leishmania -induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. Journal of Infectious Diseases 2002 185 5 673 681 2-s2.0-0036498872 10.1086/339260 (Pubitemid 34171473)
24. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M., The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 2004 25 12 677 686 2-s2.0-7644231561 10.1016/j.it.2004.09. 015 (Pubitemid 39457982)
25. Gallardo-Soler A., Gómez-Nieto C., Campo M. L., Marathe C., Tontonoz P., Castrillo A., Corraliza I., Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor- γ / δ -mediated effect that links lipid metabolism and immunity. Molecular Endocrinology 2008 22 6 1394 1402 2-s2.0-44649105230 10.1210/me.2007-0525 (Pubitemid 351786999)
26. Adapala N., Chan M. M., Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral Leishmaniasis in a chronic experimental model. Laboratory Investigation 2008 88 12 1329 1339 2-s2.0-56649094498 10.1038/labinvest.2008.90
27. Noverr M. C., Erb-Downward J. R., Huffnagle G. B., Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clinical Microbiology Reviews 2003 16 3 517 533 2-s2.0-0038107709 10.1128/CMR.16.3.517- 533.2003 (Pubitemid 36871319)
28. 2 Journal of Biological Chemistry 1997 272 27 16709 16712 2-s2.0-0030836586 10.1074/jbc.272.27.16709 (Pubitemid 27289760)
29. Okamoto F., Saeki K., Sumimoto H., Yamasaki S., Yokomizo T., Leukotriene B4 augments and restores Fc γ Rs-dependent phagocytosis in macrophages. Journal of Biological Chemistry 2010 285 52 41113 41121 2-s2.0-78650316623 10.1074/jbc.M110.175497
30. 2 synthesis. Parasite Immunology 2001 23 4 177 184 2-s2.0-0035039254 10.1046/j.1365-3024.2001.00372.x (Pubitemid 32391390)
31. 2 mediates peroxisome proliferator-activated receptor γ activation in human lung epithelial cells. Journal of Biological Chemistry 2002 277 36 33153 33163 2-s2.0-0037031820 10.1074/jbc.M200246200 (Pubitemid 34984833)
32. 2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors γ 1 and 2 in human lung cells. Journal of Biological Chemistry 2004 279 47 48550 48561 2-s2.0-10344233226 10.1074/jbc.M408926200 (Pubitemid 39625729)
33. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 (Pubitemid 37328697)
34. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity. Nature Reviews Immunology 2005 5 12 953 964 2-s2.0-28544446111 10.1038/nri1733 (Pubitemid 41746764)
35. Martinez F. O., Gordon S., Locati M., Mantovani A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of Immunology 2006 177 10 7303 7311 2-s2.0-33750813483 (Pubitemid 44715100)
36. 2 Biochemical and Biophysical Research Communications 2011 416 3-4 325 330 10.1016/j.bbrc.2011.11.034
37. Rodriguez M. L., Rodriguez S., Gonzalez A. E., Verastegui M., Bernal T., Jimenez J. A., Garcia H. H., Can taenia solium latent post-oncospheral stages be found in muscle tissue of cysticercosis-infected pigs (Sus scrofa)? Journal of Parasitology 2006 92 1 199 201 2-s2.0-33645544260 10.1645/GE-571R1.1
38. Bosisio D., Polentarutti N., Sironi M., Bernasconi S., Miyake K., Webb G. R., Martin M. U., Mantovani A., Muzio M., Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon- γ: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002 99 9 3427 3431 2-s2.0-0036565888 10.1182/blood.V99.9.3427 (Pubitemid 34525326)
39. Odegaard J. I., Ricardo-Gonzalez R. R., Goforth M. H., Morel C. R., Subramanian V., Mukundan L., Eagle A. R., Vats D., Brombacher F., Ferrante A. W., Chawla A., Macrophage-specific PPAR γ controls alternative activation and improves insulin resistance. Nature 2007 447 7148 1116 1120 2-s2.0-34347354309 10.1038/nature05894 (Pubitemid 47014427)
40. Chan M. M., Adapala N., Chen C., Peroxisome proliferator-activated receptor- γ -mediated polarization of macrophages in Leishmania infection. PPAR Research 2012 2012 11 796235 10.1155/2012/796235
41. 2 (PCPP) axis in inflammostasis. Inflammation Research 2011 60 12 1083 1092 10.1007/s00011-011-0385-7
42. 2 through cAMP. Mediators of Inflammation 1999 8 6 287 294 2-s2.0-0033494228 (Pubitemid 30232874)
43. Murray H. W., Cell-mediated immune response in experimental visceral Leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. Journal of Immunology 1982 129 1 351 357 2-s2.0-0019978017 (Pubitemid 12080715)
44. Zarley J. H., Britigan B. E., Wilson M. E., Hydrogen peroxide-mediated toxicity for Leishmania donovani chagasi promastigotes: role of hydroxyl radical and protection by heat shock. Journal of Clinical Investigation 1991 88 5 1511 1521 2-s2.0-0025887577
45. Dermine J. F., Goyette G., Houde M., Turco S. J., Desjardins M., Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cellular Microbiology 2005 7 9 1263 1270 2-s2.0-23844543738 10.1111/j.1462-5822.2005.00550.x (Pubitemid 41179419)
46. Stachowska E., Baśkiewicz-Masiuk M., Dziedziejko V., Gutowska I., Baranowska-Bosiacka I., Marchlewicz M., Dołegowska B., Wiszniewska B., Machaliński B., Chlubek D., Conjugated linoleic acid increases intracellular ROS synthesis and oxygenation of arachidonic acid in macrophages. Nutrition 2008 24 2 187 199 2-s2.0-37349043623 10.1016/j.nut.2007.10.018 (Pubitemid 350299849)
47. Gervois P., Fruchart J. C., Staels B., Drug insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nature Clinical Practice Endocrinology and Metabolism 2007 3 2 145 156 2-s2.0-33846429592 10.1038/ncpendmet0397 (Pubitemid 46146967)
48. Serghides L., Patel S. N., Ayi K., Lu Z., Gowda D. C., Liles W. C., Kain K. C., Rosiglitazone modulates the innate immune response to plasmodium falciparum infection and improves outcome in experimental cerebral malaria. Journal of Infectious Diseases 2009 199 10 1536 1545 2-s2.0-65549159340 10.1086/598222
49. Teixeira M. J., Dumet Fernandes J., Romero Teixeira C., Bezerril Andrade B., Lima Pompeu M., Santana Da Silva J., Brodskyn C. I., Barral-Netto M., Barral A., Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infection and Immunity 2005 73 2 1191 1195 2-s2.0-12844281211 10.1128/IAI.73.2.1191-1195.2005 (Pubitemid 40165780)